|
|
Article: Comfort level of ocular allergy agent is key to patient compliance
- Article from:
- Ophthalmology Times
- Article date:
- April 15, 2002
- Author:
CopyrightCopyright Advanstar Communications, Inc. Apr 15, 2002. Provided by ProQuest LLC. (Hide copyright information)
|
Alleviating symptoms
Patients experienced less discomfort using pemirolast potassium for seasonal allergic conjunctivitis
San Antonio, TX-A treatment for seasonal allergic conjunctivitis, pemirolast potassium 0.1% ophthalmic solution (Alamast, Santen Inc., Napa, CA), was shown to be more comfortable for patients and equally effective when used twice a day during ragweed season when compared with nedocromil sodium 2% ophthalmic solution (Alocril, Allergan, Irvine, CA). These two drugs are the two latest mast-cell stabilizers that have become commercially available to treat ocular allergies.
The study was a single-center, randomized, double-masked trial in which adults with seasonal ...